Evidence map›Paper›PMID 40806393›Full record

ArticleInternational journal of molecular sciences2025

Assessment of Eotaxin Concentration in Children with Chronic Kidney Disease.

Marta Badeńska, Andrzej Badeński, Elżbieta Świętochowska, Artur Janek, Karolina Marczak, Aleksandra Gliwińska, Maria Szczepańska

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marta BadeńskaDepartment of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3 Maja 13/15, 41-800 Zabrze, Poland.ORCID 0000-0003-1711-8067
Andrzej BadeńskiDepartment of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3 Maja 13/15, 41-800 Zabrze, Poland.ORCID 0000-0001-6947-005X
Elżbieta ŚwiętochowskaDepartment of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Katowice, Poland.
Artur JanekClinical Department of Pediatrics, Specialist Hospital No. 2 in Bytom, ul. Batorego 15, 41-902 Bytom, Poland.ORCID 0009-0009-6925-8409
Karolina MarczakDepartment of Pediatric Nephrology with Dialysis Division for Children, Public Clinical Hospital No. 1 in Zabrze, 41-800 Zabrze, Poland.ORCID 0000-0002-5960-5229
Aleksandra GliwińskaDepartment of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3 Maja 13/15, 41-800 Zabrze, Poland.
Maria SzczepańskaDepartment of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3 Maja 13/15, 41-800 Zabrze, Poland.ORCID 0000-0002-6772-1983

Funding

European Union FESL: NWD/2441/2024Medical University of Silesia PCN-1-173/K/0/K
6 · The paper itself

Abstract

Chronic kidney disease (CKD) is a progressive condition which still leads to significant morbidity and mortality among patients at all ages. Its proper management should be focused on slowing down the disease sequelae, as well as establishing an early diagnosis and treatment of its complications. Eotaxin is a potent, selective eosinophil chemoattractant, which is reported to have an impact on various kidney diseases. Nevertheless, data regarding the potential correlation between eotaxin and CKD in a pediatric population is still scarce. This study aims to assess the concentration of eotaxin in children with CKD and evaluate potential correlations with selected biochemical markers and disease occurrence. Both serum and urine eotaxin concentrations were markedly higher in children with CKD compared to healthy controls. Moreover, Receiver Operating Characteristic (ROC) curves have shown that serum eotaxin and urine eotaxin levels demonstrated high sensitivity and high specificity for the allocation of patients to the study and control groups. The authors advanced a thesis that eotaxin might serve as a marker of CKD occurrence in a pediatric population. Such a research design is innovative, since it has not been analyzed in the literature yet. However, further studies are required.

Indexed as

Chemokine CCL11Renal Insufficiency, ChronicAdolescentBiomarkersCase-Control StudiesChildChild, PreschoolFemaleHumansMaleROC CurveBiomarkersCCL11 protein, humanChemokine CCL11childrenchronic kidney diseaseeosinophil chemotactic factoreotaxin

Identifiers

PMID40806393
PMCPMC12346741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.